On June 17, 2025, Beneficient completed a primary capital transaction involving a limited partner interest with a net asset value of approximately $1.91 million, exchanging it for 191,037 shares of Series B-8 Convertible Preferred Stock, which can be converted into Class A Common Stock at a conversion price starting at $0.3397.